Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 Intracellular distribution and

Published byΙσοκράτης Ζαφειρόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 4 Intracellular distribution and"— Presentation transcript:

1 Figure 4 Intracellular distribution and
compartment-specific interactome of OCRL in proximal tubular cells Figure 4 | Intracellular distribution and compartment-specific interactome of OCRL in proximal tubular cells. OCRL (blue structures) localizes at different intracellular compartments where it interacts with various large sets of proteins. The boxes list the compartment-specific interactomes of OCRL. The information on protein interactors is obtained from various sources71,105,134,135,136,137,138,139,140,141,142,143,144,145. ER, endoplasmic reticulum. De Matteis, M. A. et al. (2017) The 5‑phosphatase OCRL in Lowe syndrome and Dent disease 2 Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 4 Intracellular distribution and"

Similar presentations

Figure 6 Cholesterol metabolism in obesity-related glomerulopathy

Figure 6 Cholesterol metabolism in obesity-related glomerulopathy
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.

Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy

Figure 2 Physiological changes in the renal system in pregnancy
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Role of the kidney in glucose homeostasis
Figure 1 Model of mechanosensation through primary cilia

Figure 1 Model of mechanosensation through primary cilia
Figure 3 The fat–intestine–kidney axis

Figure 3 The fat–intestine–kidney axis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 The structure of the glycocalyx

Figure 1 The structure of the glycocalyx
Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.

Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.
Figure 7 The efficacy of phosphate-binder therapy

Figure 7 The efficacy of phosphate-binder therapy

Similar presentations

Ads by Google